中国儿科心力衰竭护理的地理空间差异:一个多中心队列研究
Muhammad Junaid Akram1,2, Yin Yue1,2, Asad Nawaz1,2
1Department of Cardiology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China.
Frontiers in public health
|February 2, 2026
概括
地理位置在中国显著影响儿科心力衰竭 (PHF) 的存活率. 西部和中部地区的儿童面临更高的死亡风险,原因是护理和疾病呈现的差异.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 地理空间分析的研究.
背景情况:
- 儿科心力衰竭 (PHF) 带来了与成人心力衰竭不同的独特挑战.
- 在中国存在显著的地理空间医疗差异,影响PHF患者的治疗结果.
- 这些差异对PHF患者个人资料,管理和存活率的影响没有量化.
研究的目的:
- 系统地检查地理位置与PHF患者个人资料之间的关联.
- 分析地理位置对PHF管理和生存结果的影响.
- 量化地理空间医疗保健差异对中国儿科心力衰竭的影响.
主要方法:
- 对2,903名初级HF诊断的儿科住院患者 (2013-2022) 的回顾性分析.
- 地理空间分层分为东部,西部和中部的中国队伍.
- 对住院死亡率的多变量逻辑回归,调整为混因素; 住院长度的玛通用线性模型.
主要成果:
- 西方患者年轻,患先天性心脏病的患病率较高,临床状况严重.
- 心肌病在东部占主导地位;指南导向医学治疗 (GDMT) 在非东部地区最低.
- 地理区域独立预测死亡率:调整后的死亡几率在西部高出2.58倍,在中国中部高出3.54倍.
结论:
- 地理位置是中国儿科心力衰竭患者生存的重要独立预测因素.
- 调查结果显示,医疗保健景观是分层的,迫切需要进行干预.
- 有针对性的干预措施对于缓解差异和通过区域能力建设和标准化转诊途径确保公平护理至关重要.
相关概念视频
01:29Heart Failure II: Pathophysiology
929
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
01:17Pathophysiology of Heart Failure
3.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
01:27Heart Failure I: Introduction
886
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
01:22Heart Failure VI: Adjunct Therapies
340
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
01:22Heart Failure Drugs: Diuretics
971
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
01:30Heart Failure V: Medical Management
319
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319